Actions for FDA warning letters : timeliness and effectiveness

Email RIS file
Bookmark
Report an Issue

FDA warning letters : timeliness and effectiveness

Corporate Author
United States. Department of Health and Human Services. Office of Inspector General
Additional Titles
Food and Drug Administration warning letters : timeliness and effectiveness and Running title: Warning letters -- timeliness and effectiveness
Published
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1999.
Physical Description
1 online resource (25 pages) : color illustrations
Access Online

Availability

I Want It
I Want It

Finding items...

Restrictions on Access
Free-to-read Unrestricted online access
Report Numbers
HE 1.75:OEI-09-97-00381
OEI-09-97-00381
Subject(s)
Note
Title from title screen (viewed June 27, 2016).
"February 1999."
"OEI-09-97-00381."
Bibliography Note
Includes bibliographical references.
Action Note
committed to retain. Federal Depository Library Program (FDLP). For information on our retention commitment, please contact Microforms and Government Information.
View MARC record | catkey: 18159026